- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x USS: 3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-2,3,4,5-tetrahydropyridin-4-yl]-1~{H}-benzimidazol-2-one(Non-covalent)
- 30 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 5 residues within 4Å:- Chain A: H.125, R.126, A.129, R.317, M.319
Ligand excluded by PLIPGOL.3: 6 residues within 4Å:- Chain A: L.157, S.259, R.262, I.288, T.418, A.419
Ligand excluded by PLIPGOL.6: 6 residues within 4Å:- Chain A: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.8: 8 residues within 4Å:- Chain A: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.9
Ligand excluded by PLIPGOL.9: 7 residues within 4Å:- Chain A: F.44, D.46, S.103, F.104, F.422
- Ligands: USS.1, GOL.8
Ligand excluded by PLIPGOL.11: 5 residues within 4Å:- Chain B: H.125, R.126, A.129, R.317, M.319
Ligand excluded by PLIPGOL.12: 6 residues within 4Å:- Chain B: L.157, S.259, R.262, I.288, T.418, A.419
Ligand excluded by PLIPGOL.15: 6 residues within 4Å:- Chain B: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.17: 8 residues within 4Å:- Chain B: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.18
Ligand excluded by PLIPGOL.18: 7 residues within 4Å:- Chain B: F.44, D.46, S.103, F.104, F.422
- Ligands: USS.10, GOL.17
Ligand excluded by PLIPGOL.20: 5 residues within 4Å:- Chain C: H.125, R.126, A.129, R.317, M.319
Ligand excluded by PLIPGOL.21: 6 residues within 4Å:- Chain C: L.157, S.259, R.262, I.288, T.418, A.419
Ligand excluded by PLIPGOL.24: 6 residues within 4Å:- Chain C: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.26: 8 residues within 4Å:- Chain C: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.27
Ligand excluded by PLIPGOL.27: 7 residues within 4Å:- Chain C: F.44, D.46, S.103, F.104, F.422
- Ligands: USS.19, GOL.26
Ligand excluded by PLIPGOL.29: 5 residues within 4Å:- Chain D: H.125, R.126, A.129, R.317, M.319
Ligand excluded by PLIPGOL.30: 6 residues within 4Å:- Chain D: L.157, S.259, R.262, I.288, T.418, A.419
Ligand excluded by PLIPGOL.33: 6 residues within 4Å:- Chain D: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.35: 8 residues within 4Å:- Chain D: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.36
Ligand excluded by PLIPGOL.36: 7 residues within 4Å:- Chain D: F.44, D.46, S.103, F.104, F.422
- Ligands: USS.28, GOL.35
Ligand excluded by PLIPGOL.38: 5 residues within 4Å:- Chain E: H.125, R.126, A.129, R.317, M.319
Ligand excluded by PLIPGOL.39: 6 residues within 4Å:- Chain E: L.157, S.259, R.262, I.288, T.418, A.419
Ligand excluded by PLIPGOL.42: 6 residues within 4Å:- Chain E: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.44: 8 residues within 4Å:- Chain E: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.45
Ligand excluded by PLIPGOL.45: 7 residues within 4Å:- Chain E: F.44, D.46, S.103, F.104, F.422
- Ligands: USS.37, GOL.44
Ligand excluded by PLIPGOL.47: 5 residues within 4Å:- Chain F: H.125, R.126, A.129, R.317, M.319
Ligand excluded by PLIPGOL.48: 6 residues within 4Å:- Chain F: L.157, S.259, R.262, I.288, T.418, A.419
Ligand excluded by PLIPGOL.51: 6 residues within 4Å:- Chain F: W.33, R.57, V.60, P.61, T.62, A.65
Ligand excluded by PLIPGOL.53: 8 residues within 4Å:- Chain F: F.44, S.103, F.104, V.105, H.139, S.141, Y.146
- Ligands: GOL.54
Ligand excluded by PLIPGOL.54: 7 residues within 4Å:- Chain F: F.44, D.46, S.103, F.104, F.422
- Ligands: USS.46, GOL.53
Ligand excluded by PLIP- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.4: 3 residues within 4Å:- Chain A: E.159, R.257, W.309
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:R.257
- Salt bridges: A:E.159
- pi-Cation interactions: A:W.309, A:W.309
DMS.5: 7 residues within 4Å:- Chain A: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.398
- Salt bridges: A:E.370
DMS.13: 3 residues within 4Å:- Chain B: E.159, R.257, W.309
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:R.257
- Salt bridges: B:E.159
- pi-Cation interactions: B:W.309, B:W.309
DMS.14: 7 residues within 4Å:- Chain B: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.398
- Salt bridges: B:E.370
DMS.22: 3 residues within 4Å:- Chain C: E.159, R.257, W.309
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:R.257
- Salt bridges: C:E.159
- pi-Cation interactions: C:W.309, C:W.309
DMS.23: 7 residues within 4Å:- Chain C: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:K.398
- Salt bridges: C:E.370
DMS.31: 3 residues within 4Å:- Chain D: E.159, R.257, W.309
4 PLIP interactions:4 interactions with chain D- Hydrogen bonds: D:R.257
- Salt bridges: D:E.159
- pi-Cation interactions: D:W.309, D:W.309
DMS.32: 7 residues within 4Å:- Chain D: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:K.398
- Salt bridges: D:E.370
DMS.40: 3 residues within 4Å:- Chain E: E.159, R.257, W.309
4 PLIP interactions:4 interactions with chain E- Hydrogen bonds: E:R.257
- Salt bridges: E:E.159
- pi-Cation interactions: E:W.309, E:W.309
DMS.41: 7 residues within 4Å:- Chain E: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:K.398
- Salt bridges: E:E.370
DMS.49: 3 residues within 4Å:- Chain F: E.159, R.257, W.309
4 PLIP interactions:4 interactions with chain F- Hydrogen bonds: F:R.257
- Salt bridges: F:E.159
- pi-Cation interactions: F:W.309, F:W.309
DMS.50: 7 residues within 4Å:- Chain F: A.367, E.368, I.369, E.370, R.396, T.397, K.398
2 PLIP interactions:2 interactions with chain F- Hydrogen bonds: F:K.398
- Salt bridges: F:E.370
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.7: 8 residues within 4Å:- Chain A: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:T.289, A:T.289
PEG.16: 8 residues within 4Å:- Chain B: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:T.289, B:T.289
PEG.25: 8 residues within 4Å:- Chain C: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:T.289, C:T.289
PEG.34: 8 residues within 4Å:- Chain D: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:T.289
PEG.43: 8 residues within 4Å:- Chain E: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:T.289
PEG.52: 8 residues within 4Å:- Chain F: L.261, H.269, I.287, T.289, H.290, D.293, P.294, Q.417
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:T.289
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance. Rsc Med Chem (2021)
- Release Date
- 2021-06-02
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
AAAC
AAAD
AAAE
AAAF
AAA
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.15 Å
- Oligo State
- homo-hexamer
- Ligands
- 6 x USS: 3-[1-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-2,3,4,5-tetrahydropyridin-4-yl]-1~{H}-benzimidazol-2-one(Non-covalent)
- 30 x GOL: GLYCEROL(Non-functional Binders)
- 12 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- 6 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Punetha, A. et al., Structure-based design of haloperidol analogues as inhibitors of acetyltransferase Eis from Mycobacterium tuberculosis to overcome kanamycin resistance. Rsc Med Chem (2021)
- Release Date
- 2021-06-02
- Peptides
- N-acetyltransferase Eis: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAAB
AAAC
AAAD
AAAE
AAAF
AAA